We are live on ! Find out more
Aberdeen Group

Aberdeen Group Portfolio holdings

AUM $61.9B
1-Year Est. Return 29.81%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
–
AUM
$64.6B
AUM Growth
+$1.37B
Cap. Flow
-$686M
Cap. Flow %
-1.06%
Top 10 Hldgs %
38.17%
Holding
995
New
43
Increased
362
Reduced
491
Closed
59

Top Buys

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$36.3M
2
SCHW
Charles Schwab
SCHW
+$36.1M
3
ASND icon
Ascendis Pharma A/S
ASND
+$35.6M
4
DHR icon
Danaher
DHR
+$30.5M
5
QURE icon
uniQure
QURE
+$28.5M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$93.5M
2
MELI icon
Mercado Libre
MELI
+$86M
3
MSFT icon
Microsoft
MSFT
+$62.9M
4
AAPL icon
Apple
AAPL
+$55.6M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$48.9M

Sector Composition

Rank Sector Weight
1 Technology 32.59%
2 Healthcare 13.39%
3 Consumer Discretionary 11.41%
4 Communication Services 11.25%
5 Financials 10.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
626
Revolution Medicines
RVMD
$38.5B
$9.02M 0.01%
+113,268
New +$7.43M
EVMN
627
Evommune Inc
EVMN
$398M
$8.99M 0.01%
+525,376
New +$9.87M
DFIN icon
628
Donnelley Financial Solutions
DFIN
$1.28B
$8.95M 0.01%
191,663
-138,532
-42% -$6.7M
RGEN icon
629
Repligen
RGEN
$6.91B
$8.9M 0.01%
54,330
– –
DTIL icon
630
Precision BioSciences
DTIL
$178M
$8.9M 0.01%
+2,138,603
New +$12.1M
WPC icon
631
W.P. Carey
WPC
$17B
$8.79M 0.01%
136,625
-10,213
-7% -$680K
PKG icon
632
Packaging Corp of America
PKG
$22.2B
$8.63M 0.01%
41,825
+47
+0.1% +$9.56K
CORT icon
633
Corcept Therapeutics
CORT
$9.98B
$8.53M 0.01%
245,093
-13,984
-5% -$1.1M
LTC
634
LTC Properties
LTC
$2.13B
$8.48M 0.01%
246,639
+1,578
+0.6% +$55.6K
DOCU
635
DocuSign
DOCU
$11.1B
$8.48M 0.01%
123,918
+7,581
+7% +$524K
WSO icon
636
Watsco Inc
WSO
$13.2B
$8.4M 0.01%
24,938
+53
+0.2% +$18.9K
VIR icon
637
Vir Biotechnology
VIR
$1.46B
$8.39M 0.01%
1,390,577
-135,688
-9% -$808K
JKHY icon
638
Jack Henry & Associates
JKHY
$11.4B
$8.36M 0.01%
45,825
-1,714
-4% -$286K
UAL icon
639
United Airlines
UAL
$38.8B
$8.25M 0.01%
73,778
-456
-0.6% -$46.1K
FUTU icon
640
Futu Holdings
FUTU
$14.3B
$8.25M 0.01%
50,219
+8,044
+19% +$1.38M
SOLS
641
Solstice Advanced Materials
SOLS
$8.84B
$8.23M 0.01%
+169,354
New +$7.97M
EQH icon
642
Equitable Holdings
EQH
$13.2B
$8.18M 0.01%
171,720
+220
+0.1% +$10.4K
FNF icon
643
Fidelity National Financial
FNF
$14.4B
$8.16M 0.01%
149,531
-1,645
-1% -$93.6K
MSTR icon
644
Strategy Inc
MSTR
$34.1B
$8.09M 0.01%
53,226
-315
-0.6% -$72.5K
BXP icon
645
Boston Properties
BXP
$11.6B
$8.07M 0.01%
119,596
+2,554
+2% +$182K
FDS icon
646
Factset
FDS
$10B
$8.04M 0.01%
27,709
-7,202
-21% -$2.02M
SNDX icon
647
Syndax Pharmaceuticals
SNDX
$1.7B
$7.83M 0.01%
372,792
– –
LENZ
648
LENZ Therapeutics
LENZ
$179M
$7.83M 0.01%
489,432
+358,706
+274% +$10.5M
BHVN icon
649
Biohaven
BHVN
$2.02B
$7.83M 0.01%
+693,452
New +$8.59M
NOC icon
650
Northrop Grumman
NOC
$76B
$7.8M 0.01%
13,681
+1,528
+13% +$887K
24 25
26
27 28

Similar funds

Mitsubishi UFJ Financial Group
Mitsubishi UFJ Financial Group Tokyo, Japan $62.1B AUM 41.06% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Aberdeen Group's Q4 2025 Portfolio in Review

As of Q4 2025, Aberdeen Group held 995 positions worth $64.6B, up 2.2% from $63.2B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Aberdeen Group's Q4 2025 filing shows 43 new, 362 increased, 491 reduced and 59 closed positions. Its largest new stake was Praxis Precision Medicines: 134,992 shares worth $39.8M. The largest sale was Eli Lilly, an estimated $93.5M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Aberdeen Group's largest Q4 2025 buy was Praxis Precision Medicines: 134,992 shares worth $39.8M.
  • Aberdeen Group added most to Nu Holdings in Q4 2025, an estimated $36.3M increase.
  • Aberdeen Group's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $93.5M.
  • Aberdeen Group fully exited BioMarin Pharmaceuticals in Q4 2025, selling an estimated $48.9M.
  • Aberdeen Group's ten largest holdings make up 38% of its $64.6B portfolio in Q4 2025.
  • Aberdeen Group opened 43 new positions and closed 59 in Q4 2025.
  • Aberdeen Group's portfolio value rose 2.2% quarter-over-quarter to $64.6B.

Based on Aberdeen Group's 13F filing for Q4 2025, filed 16 Jan 2026.